Enzymotec (ENZY): Cutting PT On Persistent Headwind - Jefferies

November 28, 2016 6:53 AM EST
Get Alerts ENZY Hot Sheet
Price: $6.35 +0.79%

Rating Summary:
    2 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade ENZY Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Jefferies analyst, Lawrence Alexander, reiterated his Hold rating on shares of Enzymotec (NASDAQ: ENZY) and cut his price target as persistent headwinds across the platform have weighed on growth.

The analyst believes Enzymotec will focus on improving the value capture in InFat while expanding, and controlling costs in Vaya. Near-term, however, the company remains hostage to sluggish end market demand and limited visibility until it can reinvent its value proposition and expand its Vaya portfolio.

A CEO transition in 1H17 could lead to a strategic change in 2018-2020 but for now he is cutting his price target to $7 from $8.

For an analyst ratings summary and ratings history on Enzymotec click here. For more ratings news on Enzymotec click here.

Shares of Enzymotec closed at $6.25 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment